Heart Disease
Research on heart disease reported by C. Godino et al
Published in Drug Week, July 9th, 2010
New research, 'Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry),' is the subject of a report. According to a study from Milan, Italy, "Limited data are available on the long-term outcome following PCI with paclitaxel-eluting stent (PES) implantation in patients with unprotected left main coronary artery (LMCA). The objective of this study was to evaluate 'real world' long-term outcome following paclitaxel-eluting stent (PES) implantation for unprotected LMCA disease in patients enrolled in the TRUE registry."
"From March 2003 to October 2004, 93 consecutive patients (81.7%...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2010-07-09)
More Articles from Drug Week
- Clinical Trial Research
Biomoda Completes Patient Enrollment and Sample Collection in Pilot Study - BioMed Central
Danish children at risk from psychotropic medicines - Depression
Data on depression reported by researchers at University of South Australia - Drug Research
Findings from California State University, Department of Psychology provide new insights into drug research - Clozapine Therapy
Findings in clozapine therapy reported from R. Hanwella and co-researchers - Schizophrenia
Investigators at Hirosaki University, Medical Department target schizophrenia - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
